Effects of osteoporosis treatment for orthopaedics surgery

Effects of osteoporosis treatment for orthopaedics surgery - Effects of osteoporosis treatment for orthopaedics surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000052358

Enrollment

200

Registered

2023-11-01

Start date

2023-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Data will be collected retrospectively from FUJIGOKO STUDY (IRB approved: registry data for the patients who diagnose and started treatment). Key inclusion criteria; Diagnosed osteoporosis treated with romosozumab, Teriparatide or Denosumab / Have DXA, Blood test and CT scan at drug initiation and 12 months.

Exclusion criteria

Exclusion criteria: Patients with malignancies, or complications that affect bone mineral conditions are excluded.

Design outcomes

Primary

Measure	Time frame
Biomechanical parameters related to orthopedic surgery	—

Secondary

Measure	Time frame
Bone mineral density	—

Countries

Japan,North America

Contacts

Public ContactKoji Ishikawa

Showa University Department of Orthopaedics Surgery

koji.ishikawa@med.showa-u.ac.jp0337848543

Outcome results